DMD – ANIMAL MODELS & PRECLINICAL TREATMENT
Angela J. Russell(University of Oxford), Karoline Koch(Healthwise), Alexis Rutledge(Texas A&M University), Yeqing Qian(Healthwise), Alvin C. Powers(Vanderbilt University Medical Center), Dennis R. Claflin(University of Michigan), Peter P. Nghiem(Texas A&M University), B. Stamper(Healthwise), Simon C. Schlachter(Healthwise), Melody G. Duvall(National Institutes of Health), Yang-Hsi Su(University of Michigan), Susan V. Brooks(University of Michigan), B. Robertson(University of Colorado Boulder), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
|Journal of Clinical Oncology|2017|411
Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
|Journal of Biological Chemistry|2002|379